|

Topotecan and Melphalan for Retinoblastoma

RECRUITINGPhase 3Sponsored by Sun Yat-sen University
Actively Recruiting
PhasePhase 3
SponsorSun Yat-sen University
Started2021-03-11
Est. completion2024-12-30
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04799002

Summary

The purpose of this study is to evaluate topotecan and melphalan for retinoblastoma patients.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* diagnosed as retinoblastoma
* receiving eyeball-sparing treatment

Exclusion Criteria:

* disease progression during follow-up

Conditions3

CancerChemotherapy EffectRetinoblastoma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.